NEW YORK (GenomeWeb) – VolitionRx said on Tuesday that it has signed an agreement with Singapore General Hospital to initiate a pilot ovarian cancer study in order to establish the feasibility of the company's NuQ assays to detect the disease. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.